CareFusion Corp.
CareFusion hits new high, confirms layoffs and outsourcing to Mexico
Updated 6/24/2014 at 5:20 p.m. EST with comments from CareFusion.
Boston Scientific’s peripherals buy bad news for Cardiovascular Systems? | Medtech Wall Street news for the week of May 19, 2014
CareFusion gets another high-risk recall over Alaris infusion pumps
The FDA this week put its highest-risk Class I label on CareFusion‘s (NYSE:CFN) latest Alaris infusion pump recall, saying that a software failure in certain models may harm patients.
CareFusion plans $1B debt offering
CareFusion (NYSE:CFN) said it plans to offer $1 billion worth of senior notes, aiming to use the proceeds to repay another, $450 million worth of senior debt that’s coming due this year.
CFN taps BSX exec for board | Medtech personnel moves for the week of May 12, 2014
CareFusion taps Boston Scientific exec Bose for board | Personnel Moves
CareFusion ChloraPrep sales make a resurgence following kickbacks scandal
California-based CareFusion (NYSE:CFN) posted a strong 3rd quarter and narrowed its full-year sales outlook, touting strong sales growth, even for its controversial ChloraPrep surgical wipes.
Smiths Medical is off the block after dismal H1 earnings
ICU Medical beats The Street, takes new CEO from CareFusion
California-based ICU Medical (NSDQ:ICUI) posted a better-than-expected Q4, concurrently announcing the appointment of Vivek Jain as its new CEO.
Medtech M&A analysis: 41 device companies sold in 2013
Total deal volume in the medical device industry contracted by about 13% in 2013, according to new analysis from audit shop PricewaterhouseCoopers.